Ryojiro Tanaka Selected Research

Hemorrhagic shock and encephalopathy syndrome

3/2022	Growth and differentiation factor-15 as a potential prognostic biomarker for status-epilepticus-associated-with-fever: A pilot study.
1/2021	Elevated cytokine, chemokine, and growth and differentiation factor-15 levels in hemorrhagic shock and encephalopathy syndrome: A retrospective observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryojiro Tanaka Research Topics

Disease

10	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 05/2002
9	IGA Glomerulonephritis (IGA Nephropathy) 06/2022 - 02/2004
9	Proteinuria 01/2021 - 02/2004
4	Nephritis 01/2022 - 07/2003
3	Seizures (Absence Seizure) 03/2022 - 08/2019
3	Brain Diseases (Brain Disorder) 03/2022 - 05/2021
3	Hemolytic-Uremic Syndrome 01/2020 - 08/2004
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2020 - 02/2006
2	Status Epilepticus (Complex Partial Status Epilepticus) 03/2022 - 03/2022
2	Hemorrhagic shock and encephalopathy syndrome 03/2022 - 01/2021
2	Fever (Fevers) 03/2022 - 08/2019
2	Purpura 01/2022 - 05/2009
2	Glomerulonephritis 01/2020 - 05/2009
2	Renal Insufficiency (Renal Failure) 10/2014 - 08/2004
1	Coma (Comas) 03/2022
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Foreign Bodies (Foreign Body) 09/2021
1	Cytokine Release Syndrome 07/2021
1	Inflammation (Inflammations) 01/2021
1	Multi-centric Castleman's Disease 12/2020
1	Peritonitis 11/2020
1	Lupus Nephritis 01/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020
1	Atrophy 01/2020
1	Hereditary Nephritis (Alport Syndrome) 01/2020
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2020
1	Renal cysts and diabetes syndrome 09/2019
1	Cakut 09/2019
1	Shock 08/2019
1	Out-of-Hospital Cardiac Arrest 01/2019
1	Sclerosis 11/2018
1	Thrombotic Thrombocytopenic Purpura 10/2018
1	Vascular System Injuries 10/2018
1	Dent Disease 05/2018
1	Atypical Hemolytic Uremic Syndrome 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Chronic Renal Insufficiency 11/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2016
1	Townes-Brocks syndrome 10/2014
1	Epilepsy (Aura) 10/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2011
1	Gastroenteritis 12/2009

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 01/2022 - 10/2014
5	SteroidsIBA 07/2021 - 05/2002
5	Immunoglobulin A (IgA)IBA 01/2021 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2012
3	Prednisolone (Predate)FDA LinkGeneric 11/2018 - 01/2011
3	CreatinineIBA 11/2018 - 08/2012
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2016 - 05/2002
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2022 - 08/2019
2	EnzymesIBA 01/2022 - 05/2009
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2021 - 08/2019
2	CytokinesIBA 01/2021 - 08/2004
2	mizoribineIBA 11/2018 - 04/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2008 - 02/2004
1	Phenobarbital (Luminal)FDA Link 03/2022
1	barbituric acid (barbiturate)IBA 03/2022
1	fosphenytoin (Cerebyx)FDA LinkGeneric 03/2022
1	Anesthetics (Anesthetic Agents)IBA 03/2022
1	BenzodiazepinesIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Growth Differentiation Factor 15IBA 03/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	Detergents (Detergent)IBA 09/2021
1	MetalsIBA 09/2021
1	Acetylglucosaminidase (NAGase)IBA 05/2021
1	ChemokinesIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 12/2020
1	galactosyl-deficient IgA1IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ElectrolytesIBA 09/2019
1	Hepatocyte Nuclear FactorsIBA 09/2019
1	Methylprednisolone FDA LinkGeneric 08/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2019
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 11/2018
1	Azathioprine (Imuran)FDA LinkGeneric 11/2018
1	Dipyridamole (Persantine)FDA LinkGeneric 11/2018
1	Warfarin (Coumadin)FDA LinkGeneric 11/2018
1	thiamine triphosphorate (TTP)IBA 10/2018
1	RNA (Ribonucleic Acid)IBA 05/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	eculizumab FDA Link 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2017
1	AlbuminsIBA 09/2017
1	A-factor (Streptomyces)IBA 01/2011

Therapy/Procedure

12	Therapeutics 06/2022 - 01/2011
3	Aftercare (After-Treatment) 01/2022 - 01/2017
1	Nephrectomy 11/2021
1	Cardiopulmonary Resuscitation (CPR) 05/2021
1	Peritoneal Dialysis 11/2020
1	Induced Hypothermia 08/2019
1	Defibrillators (Defibrillator) 01/2019
1	Transplantation 01/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2014